GLAXF GSK plc

NEUTRAL Impact: 3/10 6-K
Horizon days Filed Apr 22, 2026 Processed 1mo ago SEC 0001654954-26-003778
Notable filing: 6-K
Latest settled — T+20d ⚠ clustered
GLAXF ▼ -5.55% at T+20d
NEUTRAL call ✗ call lost -5.55% · α vs SPY -8.71% · entry $27.21 → $25.70
Next anchor: T+60d in 5w
Last close $24.66 (close Jun 8) · -9.37% from $27.21 entry
Entry anchored
Apr 22, 2026
via day open
T+1d
0.00%
call 0.00% · α +0.39%
$27.21
settled 7w ago
T+5d
+0.37%
call +0.37% · α +0.31%
$27.31
settled 6w ago
T+20d
-5.55%
call -5.55% · α -8.71%
$25.70
settled 21d ago
T+60d
call — · α —
in 5w

Price Chart

Loading chart...

Executive Summary

GSK plc purchased 335,000 of its ordinary shares on April 21, 2026, at a volume-weighted average price of 2,103.08 GBp per share, as part of its ongoing buyback program. This transaction increases the company's treasury shares to 260.4 million, representing 6.42% of total voting rights.

Actionable Insight

Monitor next quarterly earnings for updates on the buyback program's total size and pace, as this routine transaction does not signal a change in capital allocation strategy.

Key Facts

  • GSK purchased 335,000 ordinary shares on April 21, 2026
  • Volume-weighted average price was 2,103.08 GBp per share
  • Total treasury shares now stand at 260,412,615 (6.42% of voting rights)
  • Part of existing buyback program announced on February 17, 2026
  • No change in financial guidance or strategic direction announced

Financial Impact

The share purchase represents approximately $705,000 in capital returned to shareholders (based on 335,000 shares at 2,103.08 GBp).

treasurySharesdilution

Risk Factors

  • Continued share buybacks could limit capital available for R&D or strategic acquisitions
  • Treasury shares represent a growing portion of capital structure at 6.42%

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-003778
Document: 0001654954-26-003778-index-headers.html0001654954-26-003778
Document: 0001654954-26-003778-index.html0001654954-26-003778
Document: 0001654954-26-003778.txt0001654954-26-003778
50 reports for GLAXF
Performance horizon
42% Hit rate 5 of 12 directional calls best @ T+5▲ +7.60%Apr 1, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
Type Now
Jun 9, 2026
today
6-K
NEUTRAL ★ 1/10
awaiting T+5
Jun 9, 2026
today
6-K
BULLISH ★ 7/10
awaiting T+5
Jun 1, 2026
8d ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$24.66 (+1.69%)
Jun 1, 2026
8d ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$24.66 (+1.69%)
May 28, 2026
12d ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$24.66 (+0.33%)
May 27, 2026
13d ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$24.66 (−3.56%)
May 26, 2026
14d ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$24.66 (−3.29%)
May 26, 2026
14d ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$24.66 (−3.29%)
May 22, 2026
18d ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$24.66 (−5.15%)
May 20, 2026
20d ago
6-K
NEUTRAL ★ 2/10
$25.70 $25.57▼ −0.51%▼ −1.74%$24.66 (−4.05%)
Showing 10 of 50

US Market Status

Market Closed — Opens in 6h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access